In this study, we observed lower levels of apolipoprotein subparticles Lp-A-II:B:C:D:E, Lp-B:E + Lp-B:C:E, Lp-B:C, and Lp-A-I in the PAD statin group compared to the PAD no statin group. The gene discussed is LPA; the disease is peripheral arterial disease.